Varex Imaging Corporation Common Stock (VREX) is a publicly traded Healthcare sector company. As of May 21, 2026, VREX trades at $8.25 with a market cap of $408.82M and a P/E ratio of -5.03. VREX moved +8.48% today. Year to date, VREX is -17.71%; over the trailing twelve months it is +24.45%. Its 52-week range spans $6.76 to $16.93. Analyst consensus is buy with an average price target of $18.00. Rallies surfaces VREX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Varex Imaging Q1 Revenue Rises 4.9% to $209.6M with EPS $0.19: Varex Imaging posted Q1 revenue of $209.6 million, up 4.9% year-over-year, with EPS of $0.19 compared to $0.07 a year ago, representing a 35.7% upside to consensus. Industrial segment revenue jumped 17.4% to $64.8 million while medical revenue was $144.8 million, flat year-over-year.
| Metric | Value |
|---|---|
| Price | $8.25 |
| Market Cap | $408.82M |
| P/E Ratio | -5.03 |
| EPS | $-1.99 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.93 |
| 52-Week Low | $6.76 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $857.50M |
| Net Income | $-82.50M |
| Gross Margin | 33.55% |
1 analysts cover VREX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $18.00.